Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma-Reference-Cited by-同舟云学术

Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma

Published:2020-03-05 Issue:6 Volume:147 Page:1519-1527
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ruan Qi¹,Wang Haolu¹²³⁴,Burke Leslie J.¹²³,Bridle Kim R.²³,Li Xinxing⁵,Zhao Chun‐Xia⁶,Crawford Darrell H.G.²³,Roberts Michael S.¹,Liang Xiaowen¹²³^ORCID

Affiliation:

1. The University of Queensland Diamantina InstituteThe University of Queensland Woolloongabba QLD Australia

2. Gallipoli Medical Research InstituteGreenslopes Private Hospital Brisbane QLD Australia

3. Faculty of MedicineThe University of Queensland Brisbane QLD Australia

4. Department of Biliary‐Pancreatic Surgery, Ren Ji Hospital, School of MedicineShanghai Jiao Tong University Shanghai China

5. Department of General Surgery, Changzheng HospitalThe Second Military Medical University Shanghai China

6. Australian Institute for Bioengineering and NanotechnologyThe University of Queensland St Lucia QLD Australia

Funder

Gallipoli Medical Research Foundation

National Health and Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32899

Reference95 articles.

1. Global trends and predictions in hepatocellular carcinoma mortality

2. The Role of Angiogenesis in Hepatocellular Carcinoma

3. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review

4. Recurrence of Hepatocellular Cancer After Resection

5. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expression;Biochemical Journal;2024-09-06

2. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells;Journal of the National Cancer Center;2024-03

3. HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma;Cancer Nanotechnology;2024-02-22

4. Mesoderm/mesenchyme homeobox l may promote tumor progression in human hepatocellular carcinoma;Advances in Clinical and Experimental Medicine;2024-02-13

5. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy;Frontiers in Immunology;2024-01-29